March 2, 2017 / 12:43 PM / in 9 months

BRIEF-Paratek Pharmaceuticals reports Q4 loss per share $1.16

March 2 (Reuters) - Paratek Pharmaceuticals Inc

* Reports full year and fourth quarter 2016 financial results and provides clinical update

* Q4 loss per share $1.16

* Q4 earnings per share view $-1.33 -- Thomson Reuters I/B/E/S

* Paratek Pharmaceuticals Inc qtrly research and development expenses $19.7 million versus $15.2 million

* Paratek Pharma - cash, cash equivalents, marketable securities will funding operating expenses, capital expenditure requirements through first half of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below